Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

TroVax Renal Immunotherapy Survival Trial

ClinicalTrials.gov ID: NCT00397345

Public ClinicalTrials.gov record NCT00397345. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 1, 2026, 12:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomised,Double-blind,Placebo-controlled,Parallel Group Study TroVax, Added to First-line Standard of Care, Prolongs Survival of Patients With Locally Advanced or Metastatic Clear Cell Renal Adenocarcinoma.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to investigate whether TroVax, when added to first line standard of care therapy, improves survival for patients with locally advanced or metastatic clear cell renal adenocarcinoma.

Study identification

NCT ID
NCT00397345
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Oxford BioMedica
Industry
Enrollment
733 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2006 (Type not available)
Primary completion
Dec 2009 (Actual)
Completion
Dec 2009 (Actual)
Last update posted
Oct 19, 2020

2006 – 2009

United States locations

U.S. sites
46
U.S. states
25
U.S. cities
40
Facility City State ZIP Site status
AZ Cancer Center Tucson Arizona 85724 —
Little Rock Hematology / Oncology Associates, P.A. Little Rock Arkansas 72205 —
La Jolla, CA La Jolla California 92093 —
The Angeles Clinic and Reseach Institute Los Angeles California 90025 —
1300 N. Vermont Ave Los Angeles California 90027 —
UCLA Urology/Oncology Los Angeles California 90095 —
Scripps Cancer Center San Diego California 92121 —
Sharp Health Care San Diego California 92823 —
UCHSC Aurora Colorado 80045 —
Washington Cancer Center Washington D.C. District of Columbia 20010 —
Broward Oncology Associates Fort Lauderdale Florida 33308 —
SCORE Physician Alliance St. Petersburg Florida 33709 —
SCORE Physician Alliance St. Petersburg Florida 33710 —
H. Lee Moffitt Cancer Center & Research Institute Tampa Florida 33612 —
Augusta Oncology Associates Augusta Georgia 30901 —
SMO-USA Inc. Canton Georgia 301115 —
North Idaho Cancer Centre Coeur d'Alene Idaho 83814 —
Patricia A. Joyce Cancer Institute Olympia Fields Illinois 60461 —
Edward H Kaplan and Associates Skokie Illinois 60076 —
St Francis Hospital Indianapolis Indiana 46107 —
Cancer Care Centre of Indiana New Albany Indiana 47150 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
Henry Ford Health System / Josephine Ford Cancer Center Detroit Michigan 48202 —
University Minnesota Fairview Medical Center Minneapolis Minnesota 55455 —
Haematology and Oncology Associates at Bridgeport Tupelo Mississippi 38801 —
Charleston Hematology and Oncology Associates, Billings Montana 59101 —
Billings Clinical Research Center Billings Montana 59107 —
Freedman Urology Las Vegas Nevada 89109 —
Norris Cotton Cancer Center / Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 —
The Cancer Center @ HUMC Hackensack New Jersey 07601 —
Columbia Presbyterian Medical Center New York New York 10032 —
Pluta Cancer Centre Rochester New York 14623 —
Piedmont Hospital, Inc. Canton Ohio 30309 —
Riverside Cancer Centre Columbus Ohio 43214 —
Heamatology and Oncology Associates Inc. Columbus Ohio 43235 —
Flower Hospital/ Promedica Health System Sylvania Ohio 43560 —
Oregon Urology Institute Springfield Oregon 97477 —
Cancer Centre of the Carolinas Greenville South Carolina 29605 —
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 —
University of Texas Medical Branch Galveston Texas 77555-0565 —
The Methodist Hospital Houston Texas 77030 —
Urology Associates of South Texas McAllen Texas 78503 —
Cancer Outreach Associates PC Abingdon Virginia 24211 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Seattle Cancer Care Alliance Seattle Washington 98109 —
Madigan Army Medical Centre Tacoma Washington 98109 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 106 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00397345, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 19, 2020 · Synced Oct 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00397345 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →